MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Immunological causes of atypical parkinsonism

    M. Cesarini, J. Etcheverry, G. Da Prat, G. Rojas, N. Gonzalez Rojas, E. Gatto (La Plata, Argentina)

    Objective: To study the clinical and biochemical features of atypical parkinsonism. Evaluate results of the immune-mediated treatment Background: Atypical parkinsonism is a heterogeneous group of…
  • 2018 International Congress

    Background pathology of ‘corticobasal degeneration (CBD) mimics’ -Japanese validation study of CBD (J-VAC study)

    T. Shimohata, I. Aiba, M. Yoshida, Y. Toyoshima, S. Murayama, T. Uchihara, T. Arai, Y. Saito, H. Takigawa, K. Hasegawa, T. Ikeuchi, M. Hasegawa, T. Komori, K. Wakabarashi, A. Tokumaru, K. Sakurai, K. J-VAC study (Gifu, Japan)

    Objective: To determine the background pathology of Japanese patients with ‘corticobasal degeneration (CBD) mimics’. Background: Recent research has focused on the development of disease-modifying treatments…
  • 2018 International Congress

    Diagnostic Impact of Movement Disorders Subspecialty Consultations at a VA Hospital

    B. Barton (Chicago, IL, USA)

    Objective: Review the impact of subspecialty care on diagnosis patterns of patients with parkinsonism at the Jesse Brown VA (JBVA), a VA Consortium center. Background:…
  • 2018 International Congress

    Objective Measurement in Routine Care of People with Parkinson’s Disease Improves Outcomes

    M. Horne, P. Farzanehfar, H. Woodrow, M. Braybrook, S. McGregor, A. Evans, F. Nicklason (Parkville, Australia)

    Objective: This pilot study was designed to use Objective Measurement (OM) of symptoms of Parkinson’s Disease (PD) to identifying the proportion of people with PD…
  • 2018 International Congress

    Effectiveness of an Activity-based Integrative Group Therapy (ParkEASE) on Health-Related-Quality of Life of People with Parkinson’s Disease and of their Caregivers: A Retrospective Pilot Study

    D. Tsang, R. Wong, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To evaluate the effectiveness of ParkEASE in improving health related quality of life(HRQoL) of people with Parkinson’s Disease(PD) and their caregivers. This pilot study…
  • 2018 International Congress

    The Quality of Life of the participants in a group singing intervention for people with Parkinson’s: A comparison across China (Beijing), South Korea (Seoul) and Australia (Brisbane)

    C. Chang, Y. Irons, E. Han, S. Kim, X. Jiang, D. Stewart (Beijing, China)

    Objective: To compare the quality of life of the group participants in ‘Sing to Beat Parkinson’s® (STBP) Projects in China, S. Korea and Australia. Background:…
  • 2018 International Congress

    Neurostructural alterations associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s disease

    C. Beal, V. Planche, C. Chassain, A. Marques, J.M. Bonny, B. Pereira, N. Vitello, M.L. Fantini, F. Durif (Clermont-Ferrand, France)

    Objective: The aim of current study was to evaluate the volumetry of subcortical structures in Parkinson's disease (PD) patients with Rapid Eye Movement (REM) Sleep…
  • 2018 International Congress

    Impact of a Parkinson’s Disease-Specific Order Set on Inpatient Medication Administration

    D. Larson, C. Zadikoff, M. Afshari, Y. Kianirad (Chicago, IL, USA)

    Objective: To determine the efficacy of a Parkinson’s Disease (PD)-Specific Electronic Medical Record (EMR) Order Set in reducing the rate of medication mis-administration for PD…
  • 2018 International Congress

    Improving clinical data collection at patients’ home in Parkinson’s disease: The Sleep Fit app

    A. Mascheroni, C. Ferlito, S. Hackethal, S. Caverzasio, E-K. Choe, Y. Luo, F. Faraci, A. Kaelin-Lang, A. Puiatti, P-L. Ratti, M. Marazza (Manno, Switzerland)

    Objective: We introduce Sleep Fit, the first tablet application to collect subjective and objective clinical data especially designed for patients with Parkinson’s Disease (PD). Background:…
  • 2018 International Congress

    The Levodopa Response Trial and the Parkinson Disease Digital Biomarker Challenge: Monitoring symptoms of Parkinson’s disease in the lab and home using wearable sensors

    J. Daneault, G. Vergara-Diaz, G. Costante, E. Fabara, G. Ferreira-Carvalho, F. Golabchi, F. Parisi, S. Sapienza, Y. Chae, P. Snyder, P. Aubin, P. Banda, D. Brunner, R. Dorsey, L. Mangravite, W. Marks, E. Neto, U. Rubin, E. Soderberg, D. Daeschler, S. Moore, S. Sieberts, L. Omberg, P. Bonato, The Parkinson's Disease Digital Biomarker DREAM Challenge Consortium (Newark, NJ, USA)

    Objective: To leverage a community of researchers and shared wearable data to develop algorithms to estimate the severity of PD specific symptoms. Background: People with…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley